Literature DB >> 21851549

Long-term outcomes of augmentation ileocystoplasty in patients with spinal cord injury: a minimum of 10 years of follow-up.

Pratik M S Gurung1, Kaka H Attar, Ahmad Abdul-Rahman, Tim Morris, Rizwan Hamid, P Julian R Shah.   

Abstract

OBJECTIVE: To report the long-term outcomes of augmentation ileocystoplasty (AIC) in patients with spinal cord injury (SCI), with a minimum follow-up period of 10 years. PATIENTS AND METHODS: We retrospectively analysed all operations performed by a single surgeon at a specialist spinal unit. Outcomes were measured by comparing preoperative and follow-up videocystometrograms (VCMGs). Complications were identified from case notes and the surgery database. Subjective assessment was through a previously validated questionnaire.
RESULTS: The mean (range) follow-up was 14.7 (10.5-20.3) years. There were 19 patients (12 males) with a mean (range) age at time of surgery of 28.9 (12-52) years. The mean (range) period from injury to surgery was 4.5 (0.3-22) years. All had suprasacral injuries. The VCMGs showed a significant improvement in bladder capacity and a decrease in intravesical pressures (P < 0.001). Long-term complications included bladder stones (n= 4); urosepsis (n= 2); vesico-ureteric reflux ([VUR]n= 2), VUR requiring ureteric re-implantation (n= 1); neurogenic detrusor overactivity ([NDO]n= 1); and laparatomy for bowel obstruction (n= 1). Surveillance cystoscopies did not detect any bladder neoplasms. The response rate for the questionnaire survey was 14/17; 13/14 patients were satisfied with the operation such that they would consider it again or recommend it to a friend. No patient reported any significant changes in either bowel habit or sexual function.
CONCLUSIONS: We found that AIC has excellent long-term outcomes in the definitive management of refractory NDO in patients with SCI. The complications of AIC appear to be more than counterbalanced by a high level of patient satisfaction with the procedure and by the achievement of the primary aim of ensuring continence and upper tract safety in these patients.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21851549     DOI: 10.1111/j.1464-410X.2011.10509.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  14 in total

Review 1.  Minimally Invasive Techniques for Bladder Reconstruction.

Authors:  Tony Nimeh; Sean Elliott
Journal:  Curr Urol Rep       Date:  2018-04-13       Impact factor: 3.092

2.  Bladder augmentation and urinary diversion for neurogenic LUTS: current indications.

Authors:  Kamran P Sajadi; Howard B Goldman
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

Review 3.  Neurogenic bladder: from diagnosis to management.

Authors:  Ellen Goldmark; Benjamin Niver; David A Ginsberg
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

Review 4.  The evaluation and management of refractory neurogenic overactive bladder.

Authors:  Raj Kurpad; Michael J Kennelly
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

5.  [Paralytic ileus after ileocystoplasty in a patient with spinal cord injury: is homeopathy helpful?].

Authors:  J Pannek; S Pannek-Rademacher; M C Jus; M S Jus
Journal:  Urologe A       Date:  2014-11       Impact factor: 0.639

6.  Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury.

Authors:  A Balanca; A Even; C Malot; E Chartier-Kastler; P Denys; C Joussain
Journal:  World J Urol       Date:  2022-06-10       Impact factor: 3.661

Review 7.  Understanding roles of porcine small intestinal submucosa in urinary bladder regeneration: identification of variable regenerative characteristics of small intestinal submucosa.

Authors:  Hsueh-Kung Lin; Shirley Yezdi Godiwalla; Blake Palmer; Dominic Frimberger; Qing Yang; Sundar V Madihally; Kar-Ming Fung; Bradley P Kropp
Journal:  Tissue Eng Part B Rev       Date:  2013-07-25       Impact factor: 6.389

Review 8.  The urological management of children with spinal cord injury.

Authors:  Jairam R Eswara; Miguel Castellan; Ricardo González; Nicolas Mendieta; Marc Cendron
Journal:  World J Urol       Date:  2018-08-13       Impact factor: 4.226

9.  Cost-effectiveness analysis of onabotulinumtoxinA (BOTOX(®)) for the management of urinary incontinence in adults with neurogenic detrusor overactivity: a UK perspective.

Authors:  Rizwan Hamid; Clara Loveman; Jim Millen; Denise Globe; Catherine Corbell; Danielle Colayco; Sanja Stanisic; Dmitry Gultyaev
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

Review 10.  Neurogenic bladder in spinal cord injury patients.

Authors:  Waleed Al Taweel; Raouf Seyam
Journal:  Res Rep Urol       Date:  2015-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.